Investigation of genetic alterations in malignant and infectious pleural fluid: preliminary results

F. Economidou, M. Zervou, K. Samara, E. Tzortzaki, S. Schiza, M. Pougounias, N. M. Siafakas (Heraklion, Crete, Greece)

Source: Annual Congress 2006 - Genetics in lung cancer
Session: Genetics in lung cancer
Session type: Electronic Poster Discussion
Number: 4685
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Economidou, M. Zervou, K. Samara, E. Tzortzaki, S. Schiza, M. Pougounias, N. M. Siafakas (Heraklion, Crete, Greece). Investigation of genetic alterations in malignant and infectious pleural fluid: preliminary results. Eur Respir J 2006; 28: Suppl. 50, 4685

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The importance of radiological findings to distinguish benign and malignant pleural diseases
Source: Annual Congress 2008 - Imaging and measurement techniques in the evaluation of pulmonary embolism, COPD and pleural diseases
Year: 2008

Heterogeneous delivery of definitive interventions in malignant pleural effusions – results from a Danish survey.
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019


Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020




Polarized cytokine profiles in the peripheral blood and pleural fluid from the patients with tuberculous pleurisy, pulmonary tuberculosis combined disease, and malignant pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 467s
Year: 2004

Comparison of multiple serum and pleural fluid biomarkers for the diagnosis of Malignant Pleural Mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Is it important to determine pleural fluid amylase in patients with malignant pleural effusions?
Source: Eur Respir J 2007; 30: Suppl. 51, 565s
Year: 2007

Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=110
Year: 2002

Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019

Correlation of HRCT findings with pleural fluid biochemical parameters and sputum bacteriology in tuberculous pelurisy: is it an extrapulmonary disease or not?
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


Association of biochemical determinants and fibrinous formation in malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Outcomes of cytology positive malignant pleural effusions; do certain malignancies predispose patients to trapped lung?
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019




Phenotyping malignant pleural effusions: why?
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017


Pleural effusion in patients with IgG4-related disease: new insights from a case series
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018




The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020




Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion?
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


Pleural fluid DNA integrity index as a diagnostic marker of malignant pleural effusion
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019




Analysis of functional, radiologic, and bronchoalveolar lavage findings in patients with diffuse parenchymal lung diseases
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007